Advocating for a world where intellectual
property law serves the public interest.
[Martin Krechmer] A new academic statement has been released today in anticipation of the plenary vote in the European Parliament on the Copyright in the Digital Single Market Directive, scheduled for 5 July, 12:00. More than 200 academics from over 25 research centres, including the leading European institutes, have signed open letters opposing Article 11 (new exclusive right for press
[Srividhya Ragavan] Abstract: The article discusses the protection regime for clinical trial data internationally and outlines the applicable protection regime. In doing so, this article outlines how the data exclusivity regime can operate in parallel with the patent regime to add a layer of protection for the data. Such protection operates at a regulatory level to delay the entry of
[ADA] Important changes to Australian copyright law passed today will protect Australia’s education, cultural and disability organisations and help them provide better services to our communities. Under the Copyright Amendment (Service Providers) Act 2018 Australian disability organisations, education providers and cultural institutions will now be covered by the copyright safe harbour scheme, which will protect them from being held liable
[Wikimedia Policy Team] This week, a dangerous copyright proposal passed a critical committee vote in the European Parliament. Article 13 of the proposed new copyright directive would require websites that host large amounts of user-generated content to apply mandatory filters to every user upload, searching for copyright infringements. This would institute new automatic gatekeepers between a user’s creation and their
[Sophie Bloemen and David Hammerstein] ... a commons approach in biomedical research & development (R&D) can help pull us out of the current crisis of over-diagnosis, over-prescription, low innovation, secrecy and sky-rocketing costs for both patients and health systems. While not exhaustive in our analysis of the many factors affecting biomedical innovation and public health, we propose entry points in
[Office of Sen. Klobuchar, Press Release] U.S. Senator Amy Klobuchar (D-MN), Ranking Member of the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, and Senator Chuck Grassley (R-IA), Chairman of the Senate Judiciary Committee, urged the Federal Trade Commission (FTC) to examine whether makers of biologic medicines are using strategies like “pay for delay” to hinder or delay
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources